MannKind

MNKD

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Westlake Village, California, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

MannKind has been a target of short sellers for a while. The current short interest of 7.92% is roughly at the average of the last 12 months (8.33%).